Pharm-Olam is now Allucent. Learn More

Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Cancer clinical trials: Recent oncology research studies in review

Oncology is a multi-faceted field of study and a popular one. Cancer clinical trials account for more than 19% of the research...

(4 minute read)

Tags: Oncology-Hematology Disease

How to Choose Sites for Cancer Trials: Central and Eastern Europe

Site location can have a significant impact on clinical trial success. Study protocols often have established timelines and...

(4 minute read)

Tags: Pharm-Olam Insights, Global Coverage

Clinical Trials Today: Recent Milestones in Rare Cancer Research

Cancer research has evolved exponentially over the last two centuries. The first time radiation was used to cure cancer happened...

(4 minute read)

Tags: Rare & Orphan Disease, Oncology-Hematology Disease

Conducting Clinical Trials in Rare Oncology

Rare oncology is a subset of Oncology that encompasses those cancers with the rarest incidence. They may be a common type like...

(4 minute read)

Tags: Rare & Orphan Disease, Oncology-Hematology Disease

Rare Disease Research in Central and Eastern Europe

There are more than 7,000 rare diseases in existence right now and together they impact millions of people around the world....

(4 minute read)

Tags: Rare & Orphan Disease

Understanding the Importance of Location in Rare Disease Studies

Rare disease isn’t rare. As a whole, more than 350 million people in the world have at least one rare disease – more than the...

(4 minute read)

Tags: Rare & Orphan Disease, Global Coverage

Impact of COVID-19 on Rare Disease Research

COVID-19 moved from a ubiquitous virus to a full-on pandemic very quickly. As countries and city centers took steps to stem the...

(4 minute read)

Tags: Rare & Orphan Disease, Pharm-Olam Insights, COVID-19

Challenges to Research in the Age of COVID

The onset of the COVID-19 pandemic has introduced a variety of challenges to “business as usual.” The virus and the ensuing risk...

(4 minute read)

Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, COVID-19

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.